How the Opioid Crisis Can and May Impact Hospice
Includes a Live Event on 09/09/2020 at 2:00 PM (EDT)
How the opioid crisis can and may impact hospice
Greg Dyke, RPh
Gregory Dyke, RPh, is a Registered Pharmacist specializing in Hospice and Palliative Care Pharmacy practice. During his career he has started two hospice pharmacies, worked for or consulted for numerous hospices and served for many years as Vice-President of Pharmacy and New Business Development for a 300+ ADC hospice in the Chicagoland area. While there he was responsible for medication use practices, ran the Nurse Practitioner-based Palliative Care Practice as well as conceived and built, from concept through service delivery, their first Hospice Inpatient Unit.
For the past 10 years he served as President of Clinical Consulting for a national Hospice Pharmacy PBM where he created the division and was responsible for the design and management of clinical initiatives for the company and its hospice partners. This included education, clinical publications, formulary design and interpretation of the impact of CMS regulations on medication use and clinical practices in hospice.
Additionally, he has served as adjunct assistant professor to two Colleges of Pharmacy, and served as the pharmacy advisor to the NHPCO Regulatory and Relatedness committees, as well as a member of numerous formulary and pharmacy and therapeutic committees.
Greg is currently a Quality and Compliance Representative for a large, multi-state hospice provider and is an Independent Hospice Pharmacy Consultant.
He received a BS in pharmacy from the University of Illinois, College of Pharmacy and has practiced end-of-life care pharmacy since 1985.